ea0099oc4.4 | Oral Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I | ECE2024
Smits Mark
, Drzazga Anna
, Galsgaard Katrine
, Lackman Jarkko
, Gerdes Victor
, van de Laar Arnold
, Bruin Sjoerd
, Rosenkilde Mette
, Holst Jens J.
Recent years have demonstrated increasing focus on augmenting secretion of glucagon-like peptide (GLP)-1 from intestinal L cells, to improve the treatment and/or prevention of obesity and type 2 diabetes. However, finding strong stimuli and identifying novel compounds has proven difficult. To discover new GLP-1 secretagogues, we gave 49 individuals (76% female, BMI 28.3±4.8 kg/m2) a high-fat liquid mixed meal (250 mL Nutridrink, Nutricia®). Plasma samples,...